35010-32-3 Usage
General Description
2-Nitro-4,5-bis(trifluoromethyl)benzenamine is a chemical compound with the molecular formula C7H3F6N2O2. It is a yellow crystalline solid that is used as a precursor in the synthesis of various pharmaceuticals and agrochemicals. The compound is highly reactive and is commonly used as a reagent in organic synthesis. It is known to be potentially harmful if ingested, inhaled, or comes into contact with the skin, and can cause irritation to the respiratory system, skin, and eyes. The compound should be handled with caution and proper safety measures should be taken when working with it.
Check Digit Verification of cas no
The CAS Registry Mumber 35010-32-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,0,1 and 0 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 35010-32:
(7*3)+(6*5)+(5*0)+(4*1)+(3*0)+(2*3)+(1*2)=63
63 % 10 = 3
So 35010-32-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H4F6N2O2/c9-7(10,11)3-1-5(15)6(16(17)18)2-4(3)8(12,13)14/h1-2H,15H2
35010-32-3Relevant articles and documents
Glycine receptor antagonists and the use thereof
-
, (2008/06/13)
Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease and Down's syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions, inducing anesthesia and treating psychosis are disclosed by administering to an animal in need of such treatment a compound having high affinity for the glycine binding site, lacking PCP side effects and which crosses the blood brain barrier of the animal. Also disclosed are novel 1,4-dihydroquinoxaline-2,3-diones, and pharmaceutical compositions thereof. Also disclosed are highly soluble ammonium salts of 1,4-dihydroquinoxaline-2,3-diones.
